As of 17 Sept 2026, Syngene International Ltd share price is ₹380.15. The stock opened at ₹380.15 and had closed at ₹378.15 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹374.75 and a high of ₹678.00. In terms of performance, Syngene International Ltd share price has decreased by 9.38% over the past six months and has decreased by 42.26% over the last year.
SYNGENE Stock Price Chart
Syngene International Ltd Overview
About SYNGENE
Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Syngene’s services include integrated drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services.
Syngene International Ltd Historical Performance
Syngene International Ltd Fundamentals
Syngene International Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 3,490.70 | 3,443.80 | 3,291.10 | 3,264.40 | 2,654.20 |
| EBITDA | 808.30 | 1,020.10 | 955.70 | 1,005.20 | 815.50 |
| Net Profit | 304.90 | 468.00 | 466.50 | 473.00 | 393.80 |
| EPS | 7.58 | 11.64 | 11.62 | 11.81 | 9.89 |
Syngene International Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 375.43 |
| Resistance 1 (R1) | 382.83 |
| Pivot Point | 380.12 |
Syngene International Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 25-Jun-2026 | 29-Apr-2026 | 26-Jun-2026 | Final | ₹1.25 |
| 27-Jun-2025 | 23-Apr-2025 | 27-Jun-2025 | Final | ₹1.25 |
| 28-Jun-2024 | 24-Apr-2024 | 28-Jun-2024 | Final | ₹1.25 |
| 30-Jun-2023 | 26-Apr-2023 | 30-Jun-2023 | Final | ₹0.50 |
| 30-Jun-2023 | 26-Apr-2023 | 30-Jun-2023 | Special | ₹0.75 |
SYNGENE Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Kiran Mazumdar Shaw | Executive Chairman |
| Peter John Bains | Managing Director & Chief Executive Officer |
| Catherine Patricia Rosenberg | Non Executive Independent Director |
Syngene International Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,696.50-0.20% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,025.00-0.49% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹870.30-1.11% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Syngene International Ltd today is ₹380.15 on NSE and ₹380.15 on BSE.
- The 52-week high of Syngene International Ltd is ₹678.00, while the 52-week low is ₹374.75.
- The current market capitalisation of Syngene International Ltd is approximately ₹15,345 crore.
- The P/E (Price-to-Earnings) ratio of Syngene International Ltd is 45.81. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Syngene International Ltd is 3.41. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Syngene International Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for SYNGENE on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Syngene International Ltd has delivered a return of approximately -54.42%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Syngene International Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 52.59% promoters, -13.96% FIIs, 28.02% DIIs, and 6.14% public shareholders.

